Congratulations to Melinda Coughlan on REDI Fellowship!

Associate Professor Melinda Coughlan has won a REDI Fellowship

MTPConnect is pleased to announce that 16 highly skilled Australian researchers, clinicians and professionals from the medical technology, biotechnology and pharmaceutical sector have secured sought-after industry placements under the REDI (Researcher Exchange and Development within Industry) Fellowship program.

Congratulations to Associate Professor Melinda Coughlan, who heads a research group in Central Clinical School's Department of Diabetes, who will undertake a six-month project with AstraZeneca, a global, science-led biopharmaceutical company in Cambridge, UK. She will work with the Renal R&D team developing industry-related skills and increasing commercial knowledge. A/Prof Coughlan will focus on targeting mitochondria therapeutically to suppress the development of or reversal of kidney disease in diabetes and other chronic kidney diseases.

See MTPConnect story.